Copper Fox Metals Inc
Change company Symbol lookup
Select an option...
CPFXF Copper Fox Metals Inc
DDAIF Daimler AG
REI Ring Energy Inc
CZSVF Goldcore Resources Ltd
AAPL Apple Inc
PMBC Pacific Mercantile Bancorp
MSFT Microsoft Corp
O Realty Income Corp
CRLBF Cresco Labs Inc
KSDIX Keeley Small Cap Dividend Value Fund Class I

Materials : Metals & Mining | Small Cap Blend
Based in Canada
Company profile

Copper Fox Metals Inc. is a development-stage company. The Company operates as an exploration and development resource company. It is focused on the exploration and development of copper projects in North America. The Company primary assets are its interest in the Schaft Creek Joint Venture with Teck Resources Limited (Teck) on the Schaft Creek copper-gold-molybdenum-silver project located in northwestern British Columbia and the Van Dyke oxide copper deposit located in Globe-Miami Mining District in Arizona. The Company's Sombrero Butte project is located in the Laramide age porphyry copper belt in Arizona. The Company's Mineral Mountain project occurs along the Jemez structural trend that hosts the Miami-Globe, Resolution, Florence and Casa Grande copper deposits/districts. The Mineral Mountain property is located between the Florence copper deposit and the Resolution copper deposit. It also holds interest in Eaglehead Project, which is a copper-gold-molybdenum-silver property.

Closing Price
Day's Change
-0.015 (-4.61%)
B/A Size
Day's High
Day's Low

10-day average volume:

Regenerative Medicine Market Size Worth $23.57 Bn By 2027; High demand for 3D bioprinting of tissues and organs to better understand their mechanism is driving revenue growth of this segment currently | Reports and Data

8:50 am ET January 18, 2021 (Globe Newswire) Print

Increased investment in advanced technologies for treatment of genetic and chronic diseases is driving growth of the regenerative medicine market. Market Size - USD 7.34 Billion in 2019, Market Growth - CAGR of 15.6%, Market Trends-Applications in COVID-19 vaccine.

The global regenerative medicine market is forecast to reach a market size of USD 23.57 Billion by 2027, and register a robustly incline revenue growth, according to a new report by Reports and Data. Primary factors driving demand for regenerative medicines are advancements in surgical technology and monitoring devices, and major increase in prevalence of complex and degenerative diseases. Upsurge in incidence of cancers has been resulting in increasing research into stem cell therapy. Growth in research and development activities in emerging countries and rising focus on stem cell research is resulting in significant growth in the global revenue of regenerative medicine market.

Stem cell technology is growing rapidly and continues to play a crucial role in regenerative medicine and the related field. This technology opens up the possibility of treating Parkinson's Disease, arthritis, and spinal cord injury. Increase in demand for stem cell technology is a major factor driving growth of the regenerative medicine market.

Request free sample of this research report at:

Recent developments in regenerative medicine for 3D bioprinting, stem cell treatment for heart repair, and vision loss has created demand for additional investments in the R&D of the technology to help with other diseases.

The COVID-19 impact:

Demand for regenerative medicine has witnessed increased demand during the COVID-19 pandemic. Regenerative medicine helps in understanding a mechanism of infection and to develop ways to prevent the spread of the virus. It is also being used to create advanced treatments to treat persons infected by the COVID-19 virus. Private companies are also using it to develop an effective vaccine for COVID-19.

Regenerative Medicine Market Size, Share & Industry Demand By Product (Tissue-Engineered Products, Cell Therapies, Gene Therapies, Progenitor & Stem Cell Therapies), By Application (Musculoskeletal Disorders, Oncology, Wound Care, By Material), and Region, Segment Forecast to 2027, To identify the key trends in the industry, click on the link below:

Further key findings from the report suggest

-- Gene therapy is a growing trend in the medical field as researchers are trying to use genetic material to reduce disease-causing versions of protein and produce new, or modify proteins. Significant progress in molecular and cellular biology is also projected to revenue growth of gene therapy segment going ahead.

-- Cancer is a growing cause of concern in today's world. Pharmaceutical companies are investing in cancer research and development of regenerative medicines to develop effective medicines to treat the disease. Oncology application segment revenue is expected to register a significantly high growth rate during the forecast period.

-- Asia Pacific market is forecast to register the highest growth rate in terms of revenue CAGR during the forecast period due to expansion of healthcare infrastructure in developing countries and increasing investment in research and development of regenerative medicine.

List of Key Companies Identified in the Regenerative Medicine Market Report:

-- MiMedx Group, Inc.

-- Merck & Co., Inc.

-- Integra LifeSciences Corporation

-- Pfizer Inc.

-- F. Hoffmann-La Roche Ltd.

-- AstraZeneca, Smith & Nephew Plc

-- Stryker Corporation

-- Amgen, Inc.

-- 3M Group

Order Now:

For the purpose of this report, Reports and Data has segmented into the global regenerative medicine market on the basis of product, application, material, and region:

-- Product Outlook (Revenue, USD Billion; 2017-2027)

    -- Tissue-Engineered Products

    -- Tissue-Engineered Products

    -- Cell Therapies

      -- Autologous Therapies

      -- Autologous Therapies

      -- Allogeneic Therapies

      -- Gene Therapies

      -- Progenitor & Stem Cell Therapies

      -- Application Outlook (Revenue, USD Billion; 2017-2027)

        -- Musculoskeletal Disorders

        -- Musculoskeletal Disorders

        -- Oncology

        -- Wound Care

        -- Dental

        -- Ocular Disorders

        -- Others

        -- Material Outlook (Revenue, USD Billion; 2017-2027)

          -- Synthetic Material

          -- Synthetic Material

          -- Biologically Derived Material

          -- Genetically Engineered Material

          -- Pharmaceuticals

          -- Regional Outlook (Revenue, USD Billion; 2017-2027)

            -- North America

              -- North America

                -- U.S.

                -- Canada

                -- Europe

                  -- Germany

                  -- Germany

                  -- UK

                  -- France

                  -- BENELUX

                  -- Rest of Europe

                  -- Asia Pacific

                    -- China

                    -- China

                    -- Japan

                    -- South Korea

                    -- Rest of APAC

                    -- MEA

                      -- Saudi Arabia

                      -- Saudi Arabia

                      -- UAE

                      -- Rest of MEA

                      -- Latin America

                        -- Brazil

                        -- Brazil

                        -- Rest of LATAM

                        Browse similar research reports:

                        Cell Therapy Market By Therapy Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Therapeutic Area (Malignancies, Autoimmune Disorders, Musculoskeletal Disorders), By Cell Type, And By End User, Forecasts To 2027

                        Tissue Engineering Market Size, Growth & Analysis, By Material, By Application (Cancer, Urology, Neurology, Dental, Cell Banking & Cord Blood, Gynecology, Integumentary/Skin, Spine, Musculoskeletal, & Orthopedics, Vascular & Cardiology), And Region, Segment Forecasts To 2027

                        Gene Expression Market By Product And Services (Equipment, Consumables, And Services), By Capacity (Low- To Mid- Plex Gene Expression Analysis And High-Plex Gene Expression Analysis), By Application (Diagnostic, Drug Discovery, Research), And Segment Forecasts To 2027

                        About Reports and Data

                        Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

                        Contact Us:

                        John W

                        Head of Business Development

                        Reports And Data | Web:

                        Direct Line: +1-800-819-3052


                        Read full Press Release at:



                        comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.